Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

July 20, 2021; 97 (3) Research Article

Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins

An In Vivo and Postmortem Study

Kaitlin B. Casaletto, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, William Honer, Julie A. Schneider, David A. Bennett, Nina Djukic, Michelle You, View ORCID ProfileSophia Weiner-Light, Corrina Fonseca, Bruce L. Miller, Joel Kramer
First published May 4, 2021, DOI: https://doi.org/10.1212/WNL.0000000000012145
Kaitlin B. Casaletto
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Zetterberg
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaj Blennow
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Brinkmalm
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Honer
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie A. Schneider
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Bennett
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nina Djukic
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle You
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophia Weiner-Light
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sophia Weiner-Light
Corrina Fonseca
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce L. Miller
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel Kramer
From the Memory and Aging Center (K.B.C., N.D., M.Y., S.W.-L., C.F., B.L.M., J.K.), Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco; Department of Psychiatry and Neurochemistry (H.Z., K.B., A.B.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B., A.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease (H.Z., K.B., A.B.), UCL Institute of Neurology, Queen ; UK Dementia Research Institute at UCL (H.Z.), London, UK; Department of Psychiatry (W.H.), University of British Columbia, Vancouver, Canada; and Department of Neurological Sciences (J.A.S., D.A.B.), Rush Medical College, Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Short Form
Citation
Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins
An In Vivo and Postmortem Study
Kaitlin B. Casaletto, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, William Honer, Julie A. Schneider, David A. Bennett, Nina Djukic, Michelle You, Sophia Weiner-Light, Corrina Fonseca, Bruce L. Miller, Joel Kramer
Neurology Jul 2021, 97 (3) e284-e297; DOI: 10.1212/WNL.0000000000012145

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
130

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objective To test the hypothesis that fundamental relationships along the amyloid, tau, and neurodegeneration (A/T/N) cascade depend on synaptic integrity in older adults in vivo and postmortem.

Methods The 2 independent observational, cross-sectional cohorts included (1) in vivo community-dwelling, clinically normal adults from the University of California, San Francisco Memory and Aging Center who completed lumbar puncture and MRI (exclusion criteria, Clinical Dementia Rating score >0) and (2) postmortem decedents from the Rush Memory and Aging Project (exclusion criteria, inability to sign informed consent). In vivo measures included CSF synaptic proteins (synaptotagmin-1, synaptosome associated protein-25, neurogranin, and growth associated protein-43), β-amyloid (Aβ42/40), tau phosphorylated at amino acid 181 (ptau181), and MRI gray matter volume (GMV). Postmortem measures captured brain tissue levels of presynaptic proteins (complexin-I, complexin-II, vesicle associated membrane protein (VAMP), and SNARE complex) and neuritic plaque and neurofibrillary tangle (NFT) counts. Regression models tested statistical moderation of synaptic protein levels along the A/T/N cascade (synaptic proteins × amyloid on tau, and synaptic proteins × tau on GMV).

Results Sixty-eight in vivo older adults (age 71 years, 43% female) and 633 decedents (age 90 years, 68% female, 34% clinically normal) were included. Each in vivo CSF synaptic protein moderated the relationship between Aβ42/40 and ptau181 (−0.23 < β < −0.12, p < 0.05) and the relationship between ptau181 and GMV (−0.49 <β < −0.32, p < 0.05). Individuals with more abnormal CSF synaptic protein demonstrated expected relationships between Aβ-ptau181 and ptau181-brain volume, effects that were absent or reversed in those with more normal CSF synaptic protein. Postmortem analyses recapitulated CSF models. More normal brain tissue levels of complexin-I, VAMP, and SNARE moderated the adverse relationship between neuritic plaque and NFT counts (−0.10 <β < −0.08, p < 0.05).

Conclusions Pathogenic relationships of Aβ and tau may depend on synaptic state. Synaptic markers may help identify risk or resilience to AD proteinopathy.

Glossary

A/T/N=
amyloid/tau/neurodegeneration;
Aβ=
β-amyloid;
AD=
Alzheimer disease;
GAP-43=
growth associated protein-43;
MAC=
Memory and Aging Center;
MAP=
Memory and Aging Project;
NFT=
neurofibrillary tangle;
Ng=
neurogranin;
ptau181=
tau phosphorylated at amino acid 181;
SNAP-25=
synaptosome associated protein-25;
SYT-1=
synaptotagmin-1;
UCSF=
University of California, San Francisco;
VAMP=
vesicle associated membrane protein

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Received October 30, 2020.
  • Accepted in final form March 31, 2021.
  • © 2021 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Study Funding
    • Disclosure
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

Dr. Robert Pitceathly and Dr. William Macken

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Alzheimer's disease
  • Cognitive aging

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease
    Marion Tible, Åsa Sandelius, Kina Höglund et al.
    Neurology, June 25, 2020
  • Article
    Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women
    Riley Bove, Elizabeth Secor, Lori B. Chibnik et al.
    Neurology, December 11, 2013
  • Articles
    APOE, vascular pathology, and the AD brain
    A. G. Yip, A. C. McKee, R. C. Green et al.
    Neurology, July 25, 2005
  • Article
    Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging
    Alifiya Kapasi, Lei Yu, Patricia A. Boyle et al.
    Neurology, August 04, 2020
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise